JNJ vs. ABT
Compare and contrast key facts about Johnson & Johnson (JNJ) and Abbott Laboratories (ABT).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: JNJ or ABT.
Correlation
The correlation between JNJ and ABT is 0.51, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
JNJ vs. ABT - Performance Comparison
Loading data...
Key characteristics
JNJ:
0.34
ABT:
1.46
JNJ:
0.62
ABT:
2.01
JNJ:
1.09
ABT:
1.26
JNJ:
0.41
ABT:
1.10
JNJ:
1.10
ABT:
6.72
JNJ:
6.37%
ABT:
4.17%
JNJ:
18.66%
ABT:
20.56%
JNJ:
-52.60%
ABT:
-45.66%
JNJ:
-9.41%
ABT:
-4.54%
Fundamentals
JNJ:
$371.06B
ABT:
$231.82B
JNJ:
$8.99
ABT:
$7.70
JNJ:
17.15
ABT:
17.30
JNJ:
1.05
ABT:
4.17
JNJ:
4.15
ABT:
5.47
JNJ:
4.75
ABT:
4.75
JNJ:
$89.33B
ABT:
$42.34B
JNJ:
$61.01B
ABT:
$23.67B
JNJ:
$34.70B
ABT:
$11.20B
Returns By Period
In the year-to-date period, JNJ achieves a 7.49% return, which is significantly lower than ABT's 18.96% return. Over the past 10 years, JNJ has underperformed ABT with an annualized return of 7.19%, while ABT has yielded a comparatively higher 12.76% annualized return.
JNJ
7.49%
1.64%
0.79%
6.18%
3.83%
7.19%
ABT
18.96%
5.50%
15.41%
29.77%
9.23%
12.76%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
JNJ vs. ABT — Risk-Adjusted Performance Rank
JNJ
ABT
JNJ vs. ABT - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Johnson & Johnson (JNJ) and Abbott Laboratories (ABT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
JNJ vs. ABT - Dividend Comparison
JNJ's dividend yield for the trailing twelve months is around 3.22%, more than ABT's 1.71% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
JNJ Johnson & Johnson | 3.22% | 3.40% | 3.00% | 2.52% | 2.45% | 2.53% | 2.57% | 2.74% | 2.38% | 2.73% | 2.87% | 2.64% |
ABT Abbott Laboratories | 1.71% | 1.95% | 1.85% | 1.71% | 1.28% | 1.32% | 1.47% | 1.55% | 1.86% | 2.71% | 2.14% | 1.95% |
Drawdowns
JNJ vs. ABT - Drawdown Comparison
The maximum JNJ drawdown since its inception was -52.60%, which is greater than ABT's maximum drawdown of -45.66%. Use the drawdown chart below to compare losses from any high point for JNJ and ABT. For additional features, visit the drawdowns tool.
Loading data...
Volatility
JNJ vs. ABT - Volatility Comparison
Johnson & Johnson (JNJ) and Abbott Laboratories (ABT) have volatilities of 5.26% and 5.15%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
JNJ vs. ABT - Financials Comparison
This section allows you to compare key financial metrics between Johnson & Johnson and Abbott Laboratories. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
JNJ vs. ABT - Profitability Comparison
JNJ - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Johnson & Johnson reported a gross profit of 14.54B and revenue of 21.89B. Therefore, the gross margin over that period was 66.4%.
ABT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Abbott Laboratories reported a gross profit of 5.89B and revenue of 10.36B. Therefore, the gross margin over that period was 56.9%.
JNJ - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Johnson & Johnson reported an operating income of 6.30B and revenue of 21.89B, resulting in an operating margin of 28.8%.
ABT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Abbott Laboratories reported an operating income of 1.69B and revenue of 10.36B, resulting in an operating margin of 16.3%.
JNJ - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Johnson & Johnson reported a net income of 11.00B and revenue of 21.89B, resulting in a net margin of 50.2%.
ABT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Abbott Laboratories reported a net income of 1.33B and revenue of 10.36B, resulting in a net margin of 12.8%.